BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Acticor Biotech First-In-Human Clinical Trial In Healthy Volunteers

  Acticor Biotech announced the agreement of Dutch Authorities for the initiation of a phase I clinical trial in healthy volunteers with its drug candidate, ACT017.

  October 17, 2017

   · 

  2 min read
• Business

  DIAGNOS Announces a New Partner in Cambodia, Garuda Health Services

  DIAGNOS announces today the addition of a new partner to cover Cambodia, Garuda Health Services.

  October 17, 2017

   · 

  4 min read
• Business

  InMode Promotes Yair Malca as New CFO

  InMode makes promotion in line with expanding company growth and device sales

  October 17, 2017

   · 

  1 min read
• ReWalk Robotics Launches Public Offering of Ordinary Shares

  ReWalk announced the commencement of its underwritten public offering of ordinary shares of the Company.

  October 17, 2017

   · 

  5 min read
• Business

  InMode Announces New President for North America, Shakil Lakhani

  Mr. Lakhani was the Executive Vice President of Sales for North America, where he managed all sales operations and established a new distribution strategy.

  October 17, 2017

   · 

  1 min read
• Pharm Country

  BioRestorative Therapies Receives Notice of Allowance for Key Metabolic Patent in Japan

  The patent will allow for a method of isolating and differentiating a non-embryonic human brown adipose-derived stem cell into functional human brown adipocytes.

  October 17, 2017

   · 

  3 min read
• Business

  Oxford Immunotec Schedules Third Quarter 2017 Earnings Release and Conference Call for October 31, 2017

  The CEO and CFO will host a conference call to review the Company’s results at 8:00 a.m. Eastern Time the same day.

  October 17, 2017

   · 

  2 min read
• Drug Development

  Incysus Announces FDA Approval of IND Application for a Phase 1 Study of a Gamma-Delta (γδ) T Cell Leukemia and Lymphoma Immunotherapy

  Incysus Announces FDA Approval of IND Application for a Phase I Study of a Gamma-Delta T Cell Leukemia and Lymphoma Immunotherapy

  October 17, 2017

   · 

  2 min read
• Bio NC

  Inivata Highlights New Clinical Data on InVision(TM) ctDNA Liquid Biopsy Platform in Advanced NSCLC at WCLC 2017

  This is the first data published using amplicon-based technology to detect ALK and ROS1 fusions.

  October 17, 2017

   · 

  3 min read
• Business

  Neximmune and the Leukemia & Lymphoma Society Enter Partnership for the Development of AIM ACT in AML Patients

  This will advance the Company’s novel cellular immunotherapy into Phase I clinical testing for patients with high risk AML who have relapsed after an allogeneic hematopoietic stem cell transplant.

  October 17, 2017

   · 

  3 min read